These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34500022)

  • 1. Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT).
    Starks MA; Jackson LR; Hellkamp A; Al-Khatib SM; Mark DB; Thomas KL; Nichol G; Lee KL; Davidson-Ray L; Poole J; Anderson J; Johnson G; Bardy GH
    Resuscitation; 2021 Nov; 168():75-83. PubMed ID: 34500022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between GRACE score at admission for myocardial infarction and the incidence of sudden cardiac arrests in long-term follow-up - the MADDEC study.
    Hautamäki M; Järvensivu-Koivunen M; Lyytikäinen LP; Eskola M; Lehtimäki T; Nikus K; Oksala N; Tynkkynen J; Hernesniemi J
    Scand Cardiovasc J; 2024 Dec; 58(1):2335905. PubMed ID: 38557164
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Piccini JP; Al-Khatib SM; Hellkamp AS; Anstrom KJ; Poole JE; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2011 Mar; 8(3):393-400. PubMed ID: 21109025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.
    Epstein AE; Abraham WT; Bianco NR; Kern KB; Mirro M; Rao SV; Rhee EK; Solomon SD; Szymkiewicz SJ
    J Am Coll Cardiol; 2013 Nov; 62(21):2000-2007. PubMed ID: 23916930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator therapy in device recipients who survived a cardiac arrest associated with a reversible cause.
    Gupta A; Pasupula DK; Bhonsale A; Kancharla K; Wang NC; Adelstein E; Jain S; Saba S
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1413-1417. PubMed ID: 30015993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials.
    Hess PL; Laird A; Edwards R; Bardy GH; Bigger JT; Buxton AE; Moss AJ; Lee KL; Hall WJ; Steinman R; Dorian P; Hallstrom A; Cappato R; Kadish AH; Kudenchuk PJ; Mark DB; Al-Khatib SM; Piccini JP; Inoue LY; Sanders GD
    Heart Rhythm; 2013 Jun; 10(6):828-35. PubMed ID: 23416381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
    Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
    Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study.
    Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C
    Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.
    Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).
    Pres D; Tajstra M; Mitkowski P; Ciślak A; Bujak K; Kaźmierczak J; Sterliński M; Mizia-Stec K; Sierpiński R; Gąsior M; Szumowski Ł; Kalarus Z
    Kardiol Pol; 2021; 79(12):1343-1352. PubMed ID: 34897630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry.
    Völler H; Kamke W; Klein HU; Block M; Reibis R; Treusch S; Contzen K; Wegscheider K;
    Europace; 2011 Apr; 13(4):499-508. PubMed ID: 21123220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Al-Khatib SM; Hellkamp AS; Lee KL; Anderson J; Poole JE; Mark DB; Bardy GH;
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1059-65. PubMed ID: 18479330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable Defibrillator Therapy in Cardiac Arrest Survivors With a Reversible Cause.
    Ladejobi A; Pasupula DK; Adhikari S; Javed A; Durrani AF; Patil S; Qin D; Ahmad S; Munir MB; Rijal S; Wayne M; Adelstein E; Jain S; Saba S
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005940. PubMed ID: 29545361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Sudden Cardiac Arrest Among Patients With Post-Myocardial Infarction Ejection Fraction Greater Than 35.
    Adabag S; Zimmerman P; Lexcen D; Cheng A
    J Am Heart Assoc; 2021 Jul; 10(14):e020993. PubMed ID: 34259015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator in patients with spontaneous coronary artery dissection presenting with sudden cardiac arrest.
    Garg J; Shah K; Shah S; Turagam MK; Natale A; Lakkireddy D
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2595-2600. PubMed ID: 34379349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical challenge of preventing sudden cardiac death immediately after acute ST-elevation myocardial infarction.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1427-37. PubMed ID: 25382137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
    Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
    Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden cardiac arrest and ventricular arrhythmias following first type I myocardial infarction in the contemporary era.
    Amin M; Kella D; Killu AM; Padmanabhan D; Hodge DO; Golafshar MA; Chamberlain AM; Lee JZ; Shen WK; Friedman PA; Asirvatham SJ; Roger VL; Gersh BJ; Mulpuru SK
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2869-2876. PubMed ID: 31588605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and factors associated to patients discharging from hospital without an implantable cardioverter defibrillator after out-of-hospital cardiac arrest.
    Sharifzadehgan A; Gaye B; Rischard J; Bougouin W; Karam N; Waldmann V; Narayanan K; Dumas F; Gandjbakhch E; Algalarrondo V; Beganton F; Extramiana F; Lellouche N; Lamhaut L; Jost D; Cariou A; Jouven X; Marijon E
    Eur Heart J Acute Cardiovasc Care; 2022 Jul; 11(7):523-531. PubMed ID: 35714122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.